163 related articles for article (PubMed ID: 24673549)
1. Recurrent longitudinal extensive transverse myelitis in a neuro-Behçet syndrome treated with infliximab.
Uygunoğlu U; Pasha M; Saip S; Siva A
J Spinal Cord Med; 2015 Jan; 38(1):111-4. PubMed ID: 24673549
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.
Kuroda R; Suzuki J; Muramatsu M; Tasaki A; Yano M; Imai N; Serizawa M; Kobari M
J Neurol; 2013 Dec; 260(12):3167-70. PubMed ID: 24178704
[No Abstract] [Full Text] [Related]
3. Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behçet's disease responding to infliximab.
Coulter I; Huda S; Baborie A; Jacob A
J Spinal Cord Med; 2012 Mar; 35(2):122-4. PubMed ID: 22333754
[TBL] [Abstract][Full Text] [Related]
4. Spinal cord involvement in Behçet's disease.
Lee HS; Kim do Y; Shin HY; Choi YC; Kim SM
Mult Scler; 2016 Jun; 22(7):960-3. PubMed ID: 26480923
[TBL] [Abstract][Full Text] [Related]
5. Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum.
Al Sawaf A; Berger JR
Mult Scler Relat Disord; 2015 Sep; 4(5):395-399. PubMed ID: 26346785
[TBL] [Abstract][Full Text] [Related]
6. Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.
Asgari N; Skejoe HP; Lillevang ST; Steenstrup T; Stenager E; Kyvik KO
BMC Neurol; 2013 Apr; 13():33. PubMed ID: 23566260
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica IgG status in acute partial transverse myelitis.
Scott TF; Kassab SL; Pittock SJ
Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis.
Imabayashi K; Ayano M; Higashioka K; Yokoyama K; Yamamoto K; Takayama K; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Akashi K; Horiuchi T; Niiro H
J Neuroimmunol; 2021 Aug; 357():577631. PubMed ID: 34153801
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica.
Chan KH; Tsang KL; Fong GC; Cheung RT; Ho SL
Clin Neurol Neurosurg; 2005 Feb; 107(2):132-5. PubMed ID: 15708229
[TBL] [Abstract][Full Text] [Related]
10. Teaching NeuroImages: longitudinally extensive transverse myelitis in neuro-Behcet disease.
Graham D; McCarthy A; Kavanagh E; O'Rourke K; Lynch T
Neurology; 2013 Apr; 80(18):e189-90. PubMed ID: 23628935
[No Abstract] [Full Text] [Related]
11. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
[TBL] [Abstract][Full Text] [Related]
12. Acute transverse myelitis at the conus medullaris level after rabies vaccination in a patient with Behçet's disease.
Bir LS; Eşmeli FO; Cenikli U; Erdoğan C; Değirmenci E
J Spinal Cord Med; 2007; 30(3):294-6. PubMed ID: 17684898
[TBL] [Abstract][Full Text] [Related]
13. Subacute longitudinal myelitis associated with Behcet's disease.
Fukae J; Noda K; Fujishima K; Takahashi T; Hattori N; Okuma Y
Intern Med; 2010; 49(4):343-7. PubMed ID: 20154443
[TBL] [Abstract][Full Text] [Related]
14. Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.
Chen Y; Shen Y; Ma HF; Cai JF; Hua YQ; Zou J; Guan JL
Medicine (Baltimore); 2017 Dec; 96(50):e9202. PubMed ID: 29390339
[TBL] [Abstract][Full Text] [Related]
15. Transverse myelitis in Behçet's disease: a series of four cases and review of the literature.
Bitik B; Ucar M; Tezcan ME; Mercan R; Tufan A; Kocer B; Ozturk MA; Haznedaroglu S; Goker B
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):20-4. PubMed ID: 23558020
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease.
Ribi C; Sztajzel R; Delavelle J; Chizzolini C
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1733-5. PubMed ID: 16291906
[TBL] [Abstract][Full Text] [Related]
17. [Infliximab treatment trial in a patient with neuro-Behçet's disease unresponsive to other treatments].
Kadowaki S; Matsuda N; Moriya A; Ebitani M; Yoshihara A; Nakamura K; Mochizuki H; Ugawa Y
Rinsho Shinkeigaku; 2011 Apr; 51(4):261-6. PubMed ID: 21595295
[TBL] [Abstract][Full Text] [Related]
18. Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
Pekcevik Y; Mitchell CH; Mealy MA; Orman G; Lee IH; Newsome SD; Thompson CB; Pardo CA; Calabresi PA; Levy M; Izbudak I
Mult Scler; 2016 Mar; 22(3):302-11. PubMed ID: 26209588
[TBL] [Abstract][Full Text] [Related]
19. Neurological Sequelae in Youngest Adult Behcet's Disease Patient on Infliximab.
Sultan M; Khan A; Habib SS; Hayat M
J Coll Physicians Surg Pak; 2020 Jul; 30(7):762-764. PubMed ID: 32811612
[TBL] [Abstract][Full Text] [Related]
20. Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation.
Chang VA; Simpson DR; Daniels GA; Piccioni DE
J Immunother Cancer; 2018 Dec; 6(1):153. PubMed ID: 30577851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
